GlassScriptPhysician profile
Alisha Bernard
NPI 1942819131
$12,648.86
in general payments reported to CMS, 2019-2025
63 companies · $2,833 in 2025
The $2,833 reported for 2025 was more than what 97% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,920 · 2022: $2,318 · 2023: $3,146 · 2024: $2,433 · 2025: $2,833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,153 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,153.41 |
| Education | $257.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,593.58 | 2021-2025 | Calquence, Imfinzi, Enhertu |
| Novartis Pharmaceuticals Corporation | $1,567.15 | 2021-2025 | |
| Janssen Biotech, INC. | $740.84 | 2021-2025 | Darzalex, Tecvayli, Carvykti |
| Daiichi Sankyo INC. | $736.03 | 2022-2025 | Enhertu, Datroway, Injectafer |
| Eisai INC. | $729.97 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $713.80 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Celgene Corporation | $462.31 | 2022-2025 | Reblozyl, Pomalyst, Opdualag |
| Pfizer INC. | $398.29 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $372.00 | 2021-2025 | Opdualag, Krazati, Opdivo |
| Amgen INC. | $329.74 | 2021-2025 | Kyprolis, Blincyto, Nplate |
| Bayer Healthcare Pharmaceuticals INC. | $310.72 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $277.89 | 2022-2025 | Ninlaro, Fruzaqla, Eohilia |
| Beigene USA, INC. | $276.06 | 2021-2025 | Brukinsa, Tevimbra |
| Glaxosmithkline, LLC. | $255.46 | 2021-2024 | Zejula, Jemperli, Ojjaara |
| Astellas Pharma US INC | $254.44 | 2022-2025 | Vyloy, Padcev, Xospata |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Deciphera Pharmaceuticals INC. | $244.53 | 2021-2024 | Qinlock |
| Genzyme Corporation | $233.24 | 2021-2025 | |
| Genmab U.S., INC. | $230.04 | 2024-2025 | Tivdak, Epkinly |
| Genentech USA, INC. | $191.12 | 2022-2025 | Itovebi, Polivy, Phesgo |
| Ipsen Biopharmaceuticals, INC | $180.14 | 2021-2025 | Onivyde, Somatuline Depot |
| Gilead Sciences, INC. | $172.70 | 2022-2025 | Trodelvy |
| Stemline Therapeutics INC. | $166.61 | 2023-2025 | Orserdu |
| Puma Biotechnology, INC. | $162.55 | 2025 | |
| Array Biopharma INC | $159.60 | 2023-2025 | Lorbrena, Braftovi, Mektovi |
| Alexion Pharmaceuticals, INC. | $152.54 | 2021-2024 | Ultomiris |
| Seagen INC. | $149.13 | 2021-2023 | Tukysa |
| Veracyte, INC. | $127.40 | 2022 | |
| Abbvie INC. | $107.03 | 2021-2025 | |
| Sobi, INC | $103.59 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $100.89 | 2023-2025 | |
| Taiho Oncology, INC. | $90.40 | 2022-2025 | |
| Incyte Corporation | $89.62 | 2022-2025 | Jakafi |
| Regeneron Healthcare Solutions, INC. | $81.33 | 2022-2025 | Libtayo |
| Karyopharm Therapeutics INC. | $71.43 | 2022-2024 | Xpovio |
| Lilly USA, LLC | $66.28 | 2021-2025 | Verzenio, Jaypirca |
| G1 Therapeutics, INC. | $63.22 | 2022-2023 | Cosela |
| Exelixis INC. | $62.88 | 2022-2025 | Cabometyx |
| Pharmacosmos Therapeutics INC. | $53.48 | 2024-2025 | Monoferric, Cosela |
| Beone Medicines USA, INC. | $44.53 | 2025 | Brukinsa |
| Tempus Ai, INC | $44.23 | 2025 | Xt Cdx |
| Adaptive Biotechnologies Corporation | $43.15 | 2025 | Clonoseq |
| Recordati_rare_diseases_inc. | $40.26 | 2023-2025 | Panhematin, Sylvant |
| Rigel Pharmaceuticals, INC. | $38.50 | 2022-2023 | Tavalisse, Rezlidhia |
| Syndax Pharmaceuticals, INC. | $23.07 | 2025 | |
| Qol Medical, LLC | $22.86 | 2025 | Sucraid |
| Acrotech Biopharma INC. | $22.35 | 2025 | Beleodaq |
| Agios Pharmaceuticals, INC. | $21.53 | 2024 | Pyrukynd |
| Ardelyx, INC. | $21.32 | 2025 | Ibsrela |
| Tg Therapeutics, INC. | $20.52 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.97 | 2025 | Talvey, Tecvayli, Darzalex |
| Tactile Systems Technology INC | $18.69 | 2024 | Entre Plus, Flexitouch Plus |
| Pharming Healthcare, INC. | $18.58 | 2023 | Ruconest |
| Ferring Pharmaceuticals INC. | $17.48 | 2025 | Adstiladrin |
| Aveo Pharmaceuticals, INC. | $17.30 | 2024 | |
| Servier Pharmaceuticals LLC | $16.68 | 2022 | |
| Sirtex Medical INC | $16.55 | 2024 | Sir-Spheres Microspheres |
| Mirati Therapeutics, INC. | $16.12 | 2023 | Krazati |
| Apellis Pharmaceuticals, INC. | $15.71 | 2023 | Empaveli |
| Morphosys, US INC. | $15.03 | 2022 | |
| Emd Serono, INC. | $14.85 | 2023 | Bavencio |
| Kite Pharma, INC. | $14.57 | 2024 | Yescarta |
| Adc Therapeutics America, INC. | $14.46 | 2023 | |
| Immunocore Limited | $13.52 | 2024 | Kimmtrak |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Bernard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.